From: Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples
MPS
Idylla™ KRAS Mutation Test
16S106
G12C (10% TTC: 31%VAF)
G12C
16K11
G12C (5-10% TTC: 33% VAF)
16O1048
G12V (10% TTC; 3% VAF)
G12V
16EM117
G12D (10% TTC, 18%VAF)
G12D